Previous Next

News Releases    Health & Medical

Translations: 


Health & Medical Results: 1946 item(s)
LAUSANNE, Switzerland and SEONGNAM-SI GYEONGGI-DO, South Korea, Feb. 26, 2021 /PRNewswire/ - Korean and Swiss based companies leverage their oncology expertise to initiate a research collaboration to formulate novel antibody-drug conjugate (ADC) candidates Genome & Company (CEO: Jisoo Pae, Hansoo Park), a global leading immuno-oncolo...
DARMSTADT, Germany, Feb. 26, 2021 /PRNewswire-AsiaNet / -- MAGNIFY-MS retrospective analysis demonstrates patients develop protective antibody levels for at least six months following seasonal influenza and varicella zoster vaccines, irrespective of vaccine timing relative to MAVENCLAD dosing Initial f...
TOKYO, Feb. 25, 2021 /Kyodo JBN-AsiaNet/-- The Polyplastics Group is expanding its DURACON (R) polyoxymethylene (POM) PM series portfolio with the development of a new high-flow grade for drug contact and delivery applications for the medical and healthcare market. The new grade, DURACON P...
GENEVA, Feb. 24, 2021 /PRNewswire-AsiaNet/ -- -- Survey also shows that half of the responding countries have agreed to include dentists in their priority vaccination groups FDI World Dental Federation today [ http://www.fdiworlddental.org/vaccines ] called for more countries to enable...
SCHAFFHAUSEN, Switzerland, February 24, 2021, /PRNewswire-AsiaNet/-- Occlutech, a privately-held company, announced today the completion of patient enrolment in its pilot study to assess safety and efficacy of the novel Atrial Flow Regulator (AFR) in heart failure (HF) patients (PRELIEVE trial). PRELIEVE is a pr...
PLYMOUTH MEETING, Pa. and GERMANTOWN, Md. and HILDEN, Germany, Feb. 24, 2021 /PRNewswire- -- Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alternative to surgical removal of cervical lesions -- QIAGEN's bioinformatic expertise raises predictive bioma...
SAN FRANCISCO, Feb. 24, 2021 /PRNewswire-Asianet/ -- A judge in the U.S. District Court for the Northern District of California has granted MGI's motion for leave to amend to add a new inequitable conduct defense of patent infringement lawsuit that Illumina filed against MGI in February 2020 (Case N...
TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire-AsiaNet / -- Following review of data from the U.S. Phase 2 study by the FDA, RedHill plans to expand the global Phase 2/3 study of orally-administered opaganib for severe COVID-19 to the U.S. The study has enrolled over 50% of the targeted 464 patients gl...
PLYMOUTH MEETING, Pa., Feb. 23, 2021 /PRNewswire-AsiaNet/ -- -- Phase 1B clinical trial is first study for Lassa fever conducted in Africa -- Goal is for vaccine to be available for emergency use as stockpile product following Phase 2 -- Progress on INO-4500 reflects INOVIO's focus on an...
SYDNEY, Feb. 23, 2021 /PRNewswire-AsiaNet/ -- -- Fastest Growing Canadian Health Technology Company Expands Into ANZ Wait times in both Australia and New Zealand are too long and how patients are admitted for surgery hasn't changed in decades. Unlike elsewhere, the process is unnecessarily...

Previous Page Page 1 of 195 Next Page 1  2  3  4  5  6  7  8  9  10  ... Go to page Go